The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.
The top performers of the launch class of 2016 have very little in common – aside from the fact that none of them came from a “classic” big pharma house.
Studies from Britain and Mexico suggest reducing sugar in sweetened drinks or taxing it more to cut consumption can help people limit their calorie intake and lower their risk of developing diabetes, but not by much. Two separate pieces of research published on Thursday in the British Medical Journal and The Lancet Diabetes & […]
Eli Lilly and Co’s new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in patients with Type 2 diabetes. In a three-year study whose results were released last summer, Jardiance became the […]
MOUNTAIN VIEW, Calif. – Google Inc. is stepping closer to developing a device to draw blood for medical testing without needles, Wired reported Monday morning. The Internet giant filed a patent application Dec. 3 on a gas-based system designed to draw blood from a fingertip to be used to test blood sugar levels. According to […]
Eli Lilly & Co said on Friday it scrapped development of an experimental diabetes treatment that had raised concerns of liver problems. Lilly had delayed applying for marketing the treatment — basal insulin peglispro — earlier in the year, after studies reported an increase in liver fat in patients. A severe buildup of fats in […]
THOUSAND OAKS, Calif. and KENILWORTH, N.J., Dec. 4, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO® (blinatumomab) in combination with KEYTRUDA® (pembrolizumab) in patients with diffuse large B-cell lymphoma (DLBCL), which […]
(Reuters Health) – Eating a handful of walnuts each day might help keep the doctor away, at least for some people who are at risk of developing diabetes, a U.S. study suggests. When people in the study added 56 grams of walnuts (2 ounces, or about 14 walnuts) to their daily diet for six months, […]
XOMA Announces License Agreement With Novo Nordisk for XMetA Program in Diabetes Novo Nordisk acquires exclusive global rights to XMetA program for the treatment of diabetes XOMA retains commercialization rights for rare disease indications $5.0 million upfront payment Agreement includes up to $290.0 million in additional potential milestone payments XOMA is entitled to tiered royalties […]
(Reuters Health) – Young adults who exercise may have a lower risk of cardiovascular disease and higher survival odds decades later than their peers who aren’t as active early in life, a U.S. study suggests. Fitness has long been linked to a reduced risk of heart disease in older adults. The new study, however, offers […]
China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. Given the 10 years or more it typically takes to bring a new medicine to market, original “Made in […]